Pro Doc Losartan Product Recall (2019-03-08) Mar 8, 2019 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type I
Lot or serial number Brand name Companies Dosage form DIN, NPN, DIN-HIM Strength 498779, 600046, 603903, 498284, 603895 B. Losartan 50mg Tablet Recalling Firm Pro Doc Ltd. 2925 Industrial Blvd. Laval H7L 3W9 Quebec CANADA Marketing Authorization Holder Pro Doc Ltd. 2925 Industrial Blvd. Laval H7L 3W9 Quebec CANADA Tablet DIN 02394375 Losartan potassium 50mg 499008, 605299, 605297 C. Losartan 100mg Tablet Recalling Firm Pro Doc Ltd. 2925 Industrial Blvd. Laval H7L 3W9 Quebec CANADA Marketing Authorization Holder Pro Doc Ltd. 2925 Industrial Blvd. Laval H7L 3W9 Quebec CANADA Tablet DIN 02394383 Losartan potassium 100mg 498292, 605344 A. Losartan 25mg Tablet Recalling Firm Pro Doc Ltd. 2925 Industrial Blvd. Laval H7L 3W9 Quebec CANADA Marketing Authorization Holder Pro Doc Ltd. 2925 Industrial Blvd. Laval H7L 3W9 Quebec CANADA Tablet DIN 02394367 Losartan potassium 25mg
Recalled Products
Losartan 25mg Tablet
Losartan 50mg Tablet
Losartan 100mg Tablet
Affected lots manufactured with an API that may contain the impurity N-nitroso-N-methyl-4-aminobutyric acid (referred as “NMBA”) above the acceptable level.